Evidence map›Paper›PMID 19924534›Full record

ReviewDigestive diseases and sciences2010

Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Linda A Feagins, Byron L Cryer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Colorectal cancer chemoprevention by mesalazine and its derivatives.Journal of biomedicine & biotechnology · 2012
    Review
  16. Managing pain in inflammatory bowel disease.Gastroenterology & hepatology · 2011
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Linda A FeaginsDivisions of Gastroenterology (111B1) and Hepatology, VA North Texas Health Care System and the University of Texas Southwestern Medical Center at Dallas, 4500 South Lancaster Road, Dallas, TX 75216, USA. LindaA.Feagins@va.gov
Byron L Cryer
The University of Texas Southwestern Medical Center · USVA North Texas Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The safety of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with inflammatory bowel disease (IBD) remains unclear. This report discusses potential mechanisms whereby NSAIDs might exacerbate IBD and reviews the available clinical data on the role of NSAIDs in causing exacerbations of ulcerative colitis (UC) and Crohn's disease (CD).

Indexed as

Anti-Inflammatory Agents, Non-SteroidalGastrointestinal TractHumansInflammatory Bowel DiseasesRecurrenceRisk FactorsAnti-Inflammatory Agents, Non-Steroidal

Identifiers

PMID19924534
OpenAlexW2116514544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.